Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection.
Wu, X., Zhang, Z., Schramm, C.A., Joyce, M.G., Do Kwon, Y., Zhou, T., Sheng, Z., Zhang, B., O'Dell, S., McKee, K., Georgiev, I.S., Chuang, G.Y., Longo, N.S., Lynch, R.M., Saunders, K.O., Soto, C., Srivatsan, S., Yang, Y., Bailer, R.T., Louder, M.K., Mullikin, J.C., Connors, M., Kwong, P.D., Mascola, J.R., Shapiro, L.(2015) Cell 161: 470-485
- PubMed: 25865483 
- DOI: 10.1016/j.cell.2015.03.004
- Primary Citation of Related Structures:  
4S1Q, 4S1R, 4S1S, 4XMP, 4XNY, 4XNZ, 4XVS, 4XVT - PubMed Abstract: 
HIV-1-neutralizing antibodies develop in most HIV-1-infected individuals, although highly effective antibodies are generally observed only after years of chronic infection. Here, we characterize the rate of maturation and extent of diversity for the lineage that produced the broadly neutralizing antibody VRC01 through longitudinal sampling of peripheral B cell transcripts over 15 years and co-crystal structures of lineage members ...